You are here

Article Text

Article menu
Download PDFPDF
Letters
Feasibility of 1 hour infliximab infusions
  1. R F van Vollenhoven,
  2. E Gullström,
  3. L Klareskog
  1. Department of Rheumatology, D2-1 Karolinska Hospital, Stockholm, Sweden
  1. Correspondence to:
    Associate Professor R F van Vollenhoven
    ronald.vanvollenhovenks.se

https://doi.org/10.1136/ard.2003.017590

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Since 1 January 2003 we have changed our routine clinical practice and now give infliximab over 1 instead of 2 hours to those patients who have had at least three uneventful prior infusions (that is, did not experience infusion related side effects). To …

    View Full Text